MedPath

Effect of baby products

Completed
Conditions
Healthy Pediatric population of the age group 01 to 36 months
Registration Number
CTRI/2022/04/041890
Lead Sponsor
Marico Limited
Brief Summary

Study will be conducted to assess the safety and efficacy of the test products. After consenting and qualifying the inclusion and exclusion criteria subjects will be enrolled into the study. For the selected subjects, the test products will be dispensed for the usage of 28 days. The assessment will be performed for week 1, 2 and 4.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Subjects in the age group 1-12 months, 12-24 months and 24-36 months in nearly equal ratio (both genders inclusive) 2.
  • Subjects in general good health as determined from a recent medical history 3.
  • Subject’s mother/authorized legal representative, preferably mother willing to give a voluntary written informed consent and agree to come for regular follow up.
  • Subject’s mother/authorized legal representative, preferably mother willing to abide by and comply with the study protocol.
  • Subject’s mother/legal representative agreeing not to use any other product of the same nature and change any habit or other regular products during the study period.
Exclusion Criteria
  • A known history or present condition or any other concern that may require medical attention 2.
  • Subejcts deemed unfit to participate in the study based on the general health and hygiene.
  • Babies whose parents and/or authorized legal guardian are not willing to sign the informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To evaluate the safety and efficacy of test products on a pediatric population by one month home use test in comparison to the baseline.4 weeeks
2. To evaluate the skin health and quality by dermatological assessment and instrumental evaluation in comparison to the baseline.4 weeeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MS Clinical Research Pvt. Ltd.

🇮🇳

Bangalore, KARNATAKA, India

MS Clinical Research Pvt. Ltd.
🇮🇳Bangalore, KARNATAKA, India
Dr Sharil Hegde
Principal investigator
08041125934
sharilhegde@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.